| ABEO |    | Abeona Therapeutics Inc. - Common Stock | | | 0 | | + Gene and cell, Medicine
| + My List |
| AGTC | | Applied Genetic Technologies Corporation - Common Stock | | | -3.85% up -7.41% 3.56 | | + Medicine, Gene and cell
| + My List |
| AKUS | | Akouos, Inc. - Common Stock | | | -8.16% -8.16% 0 | | + Gene and cell, Disease: Ear/Nose, Medicine
| + My List |
| ALLO | | Allogene Therapeutics, Inc. - Common Stock | | | 4.34% up -11.24% 15.58 | | + Cancer fight, Gene and cell, Medicine
| + My List |
| APDN | | Applied DNA Sciences, Inc. - Common Stock | | | -3.45% down 16.38% -19.83 | | + Medicine, Gene and cell
| + My List |
| ATHX | | Athersys, Inc. - Common Stock | | | up -7.92% 7.92 | | + Medicine, Immunology, Gene and cell, Disease: Cardiovascular, Disease: Neurology/Alzheimer/Parkinson's
| + My List |
| AUTL | | Autolus Therapeutics plc - American Depositary Shares | | | 13.33% 13.33% 0 | | + Country: Greate Britain, Gene and cell, Cancer fight, Medicine
Last highlighted: $AUTL Autolus Therapeutics to Report First Quarter 2021 Financial Results and Host Conference Call on May 6
https://t.co/Bswi1mwqgf | + My List |
| AVRO | | AVROBIO, Inc. - Common Stock | | | 0.97% up -7.69% 8.66 | | + Gene and cell, Pain fight, Medicine
| + My List |
| AVXL | | Anavex Life Sciences Corp. - Common Stock | | | -3.22% down 8.33% -11.55 | | + Gene and cell, Disease: Neurology/Alzheimer/Parkinson's, Medicine
| + My List |
| BBIO | | BridgeBio Pharma, Inc. - Common Stock | | | -1.66% -1.66% 0 | | + Gene and cell
Last highlighted: $BBIO 📜 SEC Form 8-K filed
https://t.co/oef6IdAzjQ
#majorpharmaceuticals #healthcare | + My List |
| BNGO | | Bionano Genomics, Inc. - Common Stock | | | 6.71% down 14.18% -7.47 | | + Medicine, Cancer fight, Gene and cell
Last highlighted: Bionano Genomics Acquires Diagnostics Services Provider Lineagen, Inc. to Accelerate Clinical Adoption of Saphyr for Digital Cytogenetics https://t.co/Q8ywclbV2i | + My List |
| BNGOW | | Bionano Genomics, Inc. - Warrant | | | 0 | | + Cancer fight, Medicine, Gene and cell
| + My List |
| BNTC | | Benitec Biopharma Inc. - Common Stock | | | -10.74% -10.74% 0 | | + Biopharma, Biotechnology, RNA, Medicine, Gene and cell
Last highlighted: Form 8-K: Regulation FD Disclosure. On February 24, 2021, Benitec Biopharma issued a presentation on the results of the interim analysis.. $BNTC https://t.co/mayyXsnb9Q | + My List |
| CABA | | Cabaletta Bio, Inc. - Common Stock | | | 23.49% 23.49% 0 | | + Gene and cell, Medicine, Immunology
| + My List |
| CDXS | | Codexis, Inc. - Common Stock | | | 1.39% down 11.26% -9.87 | | + Medicine, Gene and cell
| + My List |
| CNTG | | Centogene N.V. - Common Shares | | | -11.76% down -11.25% -0.51 | | + Gene and cell, Medicine
Last highlighted: #CNTG SEC report: Centogene N.V. Report of proposed sale of securities
SEC Filing Form 144 filed by Centogene N.V. -- SEC File Number 211084208 | + My List |
| CYCC | | Cyclacel Pharmaceuticals, Inc. - Common Stock | | | 2.21% down 7.75% -5.54 | | + Biotechnology, Biopharma, Pharmaceutical , Medicine, Gene and cell
- Bad infrastructure
| + My List |
| DTIL | | Precision BioSciences, Inc. - Common Stock | | | -2.2% down 8.79% -10.99 | | + Cancer fight, Gene and cell, Food
| + My List |
| DYN | | Dyne Therapeutics, Inc. - Common Stock | | | -6.52% down 11.94% -18.46 | | + Gene and cell, Medicine
Last highlighted: #DYN SEC report: Dyne Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Dyne Therapeutics, Inc. -- SEC File Number | + My List |
| EDIT | | Editas Medicine, Inc. - Common Stock | | | -2.05% down 11.5% -13.55 | | + Medicine, Gene and cell
Last highlighted: #EDIT SEC report: Editas Medicine, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Editas Medicine, Inc. -- SEC File Number 211142329 | + My List |
| EPZM | | Epizyme, Inc. - Common Stock | | | 0 | | + Cancer fight, Gene and cell
| + My List |
| EVLO | | Evelo Biosciences, Inc. - Common Stock | | | 4.52% down 14.81% -10.29 | | + Medicine, Gene and cell
| + My List |
| FHTX | | Foghorn Therapeutics Inc. - Common Stock | | | 6.26% down 11.03% -4.77 | | + Medicine, Gene and cell
Last highlighted: #FHTX SEC report: Foghorn Therapeutics Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Foghorn Therapeutics Inc. -- SEC File Number 211089297 | + My List |
| FREQ | | Frequency Therapeutics, Inc. - Common Stock | | | -6.92% -6.92% 0 | | + Medicine, Disease: Ear/Nose, Gene and cell
Last highlighted: $FREQ 📜 SEC Form 8-K filed by Frequency Therapeutics, Inc.
https://t.co/BVOsAkh3ww
#majorpharmaceuticals #healthcare | + My List |
| FRLN | | Freeline Therapeutics Holdings plc - ADSs | | | -7.84% -7.84% 0 | | + Medicine, Biotechnology, Gene and cell
| + My List |
| FULC | | Fulcrum Therapeutics, Inc. - Common Stock | | | 0.73% down 9.81% -9.08 | | + Medicine, Gene and cell
Last highlighted: #FULC SEC report: Fulcrum Therapeutics, Inc. Statement of acquisition of beneficial ownership by individuals
SEC Filing Form SC 13G filed by Fulcrum Therapeutics, Inc. -- SEC File Number 211160928 | + My List |
| GBIO | | Generation Bio Co. - Common stock | | | 5.51% down 7.17% -1.66 | | + Gene and cell, Medicine
Last highlighted: #GBIO SEC report: Generation Bio Co. Current report, items 1.01 and 9.01
SEC Filing Form 8-K filed by Generation Bio Co. -- SEC File Number 211089285 | + My List |
| IGMS | | IGM Biosciences, Inc. - Common Stock | | | -0.42% down 8.83% -9.25 | | + Biotechnology, Gene and cell, Medicine
Last highlighted: #IGMS SEC report: IGM Biosciences, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by IGM Biosciences, Inc. -- SEC File Number | + My List |
| ILMN | | Illumina, Inc. - Common Stock | | | -6.04% up -20.6% 14.56 | | + Medicine, Gene and cell, Biology, Cancer fight, Reproductive health
Last highlighted: #ILMN SEC report: ILLUMINA, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by ILLUMINA, INC. -- SEC File Number 211148268 | + My List |
| IOVA | | Iovance Biotherapeutics, Inc. - Common Stock | | | 1.15% down 8.46% -7.31 | | + Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based
Last highlighted: #IOVA SEC report: IOVANCE BIOTHERAPEUTICS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by IOVANCE BIOTHERAPEUTICS, INC. -- SEC File Number 211148127 | + My List |
| LRMR | | Larimar Therapeutics, Inc. - Common Stock | | | -0.78% up -7.91% 7.13 | | + Medicine, Gene and cell, Biotechnology
| + My List |
| MBIO | | Mustang Bio, Inc. - Common Stock | | | 0 | | + Medicine, Gene and cell
Last highlighted: $MBIO 📜 SEC Form 8-K filed by Mustang Bio, Inc.
https://t.co/rBa024MAHc
#healthcare #majorpharmaceuticals | + My List |
| MGTA | | Magenta Therapeutics, Inc. - Common Stock | | | 33.9% 33.9% 0 | | + Gene and cell, Cancer fight, Blood, Immunology, Medicine
Last highlighted: #MGTA SEC report: Magenta Therapeutics, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Magenta Therapeutics, Inc. -- SEC File Number 211084159 | + My List |
| MYGN | | Myriad Genetics, Inc. - Common Stock | | | -4.27% up -7.38% 3.11 | | + Gene and cell, Medicine, Women Health
Last highlighted: $MYGN SEC Filing: 8-K Earnings - MYRIAD GENETICS INC (0000899923) August 03
https://t.co/GlGu9uVj6k | + My List |
| NBSE | | NeuBase Therapeutics, Inc. - Common Stock | | | down 8% -8 | | + Medicine, Gene and cell
Last highlighted: #NBSE SEC report: NeuBase Therapeutics, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by NeuBase Therapeutics, Inc. -- SEC File Number 211078875 | + My List |
| NTLA | | Intellia Therapeutics, Inc. - Common Stock | | | -4.32% down 10.42% -14.74 | | + Medicine, Gene and cell, Biotechnology, Biopharma
| + My List |
| ORGS | | Orgenesis Inc. - Common Stock | | | -8.26% -8.26% 0 | | + Biotechnology, Medicine, Gene and cell
Last highlighted: Filing Alert, FORM 10-Q [Quarterly Report] available. $ORGS #Orgenesis Inc. Orgenesis Inc https://t.co/cwDFhLgUnk | + My List |
| ORTX | | Orchard Therapeutics plc - American Depositary Shares | | | 0 | | + Medicine, Gene and cell
Last highlighted: #ORTX SEC report: Orchard Therapeutics plc Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Orchard Therapeutics plc -- SEC File Number 211142307 | + My List |
| PASG | | Passage Bio, Inc. - Common Stock | | | -1.67% down 8.09% -9.76 | | + Gene and cell, Medicine
Last highlighted: #PASG SEC report: Passage BIO, Inc. Current report, item 5.02
SEC Filing Form 8-K filed by Passage BIO, Inc. -- SEC File Number 211102754 | + My List |
| PGEN | | Precigen, Inc. - Common Stock | | | -5.19% down 8% -13.19 | | + Biopharma, Gene and cell, Medicine
Last highlighted: #PGEN SEC report: PRECIGEN, INC. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by PRECIGEN, INC. -- SEC File Number | + My List |
| PRAX | | Praxis Precision Medicines, Inc. - Common Stock | | | 4.38% down 12.62% -8.24 | | + Biopharma, Gene and cell, Disease: Central nervous system (CNS), Medicine
Last highlighted: Research Analysts Set Expectations for Praxis Precision Medicines, Inc.’s Q1 2022 Earnings $PRAX https://t.co/u6zv6m9Tyz #markets | + My List |
| PROG | | Progenity, Inc. - Common Stock | | | -10% -10% 0 | | + Gene and cell, Medicine, Cancer fight, Women Health
Last highlighted: #PROG SEC report: PROGENITY, INC. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by PROGENITY, INC. -- SEC File Number | + My List |
| PSTX | | Poseida Therapeutics, Inc. - Common Stock | | | 0.46% down 10.55% -10.09 | | + Medicine, Gene and cell
Last highlighted: #PSTX SEC report: Poseida Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Poseida Therapeutics, Inc. -- SEC File Number | + My List |
| RGNX | | REGENXBIO Inc. - Common Stock | | | -7.44% -7.44% 0 | | + Gene and cell, Biotechnology, Medicine
| + My List |
| RNA | | Avidity Biosciences, Inc. - Common Stock | | | -10.19% -10.19% 0 | | + Medicine, Gene and cell
Last highlighted: #RNA SEC report: Avidity Biosciences, Inc. Prospectus [Rule 424(b)(5)]
SEC Filing Form 424B5 filed by Avidity Biosciences, Inc. -- SEC File Number 211136619 | + My List |
| RUBY | | Rubius Therapeutics, Inc. - Common Stock | | | -13.51% -13.51% 0 | | + Gene and cell, Cancer fight, Medicine
| + My List |
| RYTM | | Rhythm Pharmaceuticals, Inc. - Common Stock | | | -0.86% up -8.49% 7.63 | | + Pharmaceutical , Gene and cell, Medicine
Last highlighted: #RYTM SEC report: RHYTHM PHARMACEUTICALS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by RHYTHM PHARMACEUTICALS, INC. -- SEC File Number 211137945 | + My List |
| SYRS | | Syros Pharmaceuticals, Inc. - common stock | | | up -16.83% 16.83 | | + Gene and cell, Medicine, Cancer fight
| + My List |
| TSHA | | Taysha Gene Therapies, Inc. - Common Stock | | | -8.22% -8.22% 0 | | + Gene and cell, Disease: Central nervous system (CNS), Medicine
| + My List |
| XCUR | | Exicure, Inc. - Common Stock | | | 0 | | + Gene and cell, Medicine
Last highlighted: $XCUR 8-K Exicure (12 May, 4:13pm)
📰 Exicure, Inc. Reports First Quarter 2021 Financial Results and Corporate Progress
https://t.co/VEYCSavonT
#XCUR #8K #Exicure #News | + My List |
| FDMT | | 4D Molecular Therapeutics, Inc. - Common Stock | | | -5.58% up -8.25% 2.67 | | + Medicine, Gene and cell, Disease: Eye
| + My List |
| LGVN | | Longeveron Inc. - common stock | | | 16.48% 16.48% 0 | | + Biotechnology, Medicine, Gene and cell, Disease: Neurology/Alzheimer/Parkinson's
| + My List |